MultiHance® 9 Image Library 9 Maravilla et al. 51F Metastatic Lung Cancer

MultiHance® (gadobenate dimeglumine) injection, 529 mg/mL Improves Visualization and Enhancement of Lesions vs. Magnevist® (gadopentetate dimeglumine)1

Maravilla et al.
51-year-old woman with metastatic lung cancer

These are representative images from reference studies; individual results may vary.

Reference: 1. Maravilla KR, Maldjian JA, Schmalfuss IM, et al. Contrast enhancement of central nervous system lesions: multicenter intraindividual crossover comparative study of two MR contrast agents. Radiology. 2006;240(2):389-400.

View Full Image Library

More cases that may interest you

Seidl et al. 70M Metastatic Lung Carcinoma

Seidl et al. 70M Metastatic Lung Carcinoma

Seidl et al. 58F Metastatic Melanoma

Seidl et al. 58F Metastatic Melanoma

Rowley et al. 55F Glioblastoma with Recurrent Disease

Rowley et al. 55F Glioblastoma with Recurrent Disease